{"cdcTestId":"2021-0008","testcaseName":"Dose #1 is Pfizer Dose #2 is Astra Zeneca Covid-19 Vaccine ","vaccineGroup":"COVID-19","evaluationTestType":"Vaccine: Invalid Usage","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1997-09-28T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-28T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)","cvx":"210","mvx":"ASZ","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-11-16T00:00:00","pastDueDate":"2022-12-13T00:00:00"},"doses":[{"dateAdministered":"2022-09-28T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)","cvx":"210","mvx":"ASZ","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-03-02T13:30:05.079","generalDescription":"This test case describes when a patient is administered a first dose of  Pfizer Covid-19 Vaccine and a second dose as AstraZeneca that the second dose is invalid and that another dose should be forecast.","changedInVersion":"4.21","reasonForChange":"v4.21 Updated past due date to 8 weeks per 02/22/22 Clinical Considerations guidelines"}